Quantcast
Don't Miss

EntreMed reports higher loss in 4Q

EntreMed Inc., of Rockville, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, reported a fourth-quarter net loss of $1.3 million, or 5 cents per diluted share, versus a net loss of $360,000, or 2 cents per diluted share, for the prior-year period.

Print, Digital & Mobile

Special Monthly Autorenew Intro Rate!
$9.99

----------
3 Months
$84.00

----------
6 Months
$162.00

----------
1 Year
$269.00


Digital & Mobile Only

1 Year
$169.00

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top